DK1887A - Anvendelse af tumornekrosefaktor som vaegtregulator - Google Patents

Anvendelse af tumornekrosefaktor som vaegtregulator

Info

Publication number
DK1887A
DK1887A DK001887A DK1887A DK1887A DK 1887 A DK1887 A DK 1887A DK 001887 A DK001887 A DK 001887A DK 1887 A DK1887 A DK 1887A DK 1887 A DK1887 A DK 1887A
Authority
DK
Denmark
Prior art keywords
weight controller
tumor cross
cross factor
factor
tumor
Prior art date
Application number
DK001887A
Other languages
English (en)
Other versions
DK1887D0 (da
Inventor
James W Larrick
Gordon M Ringold
David F Mark
Leo S Lin
Frank M Torti
Original Assignee
Cetus Corp
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp, Univ Leland Stanford Junior filed Critical Cetus Corp
Publication of DK1887D0 publication Critical patent/DK1887D0/da
Publication of DK1887A publication Critical patent/DK1887A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/144—Tumor necrosis factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK001887A 1985-05-02 1987-01-02 Anvendelse af tumornekrosefaktor som vaegtregulator DK1887A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73036785A 1985-05-02 1985-05-02
US06/801,989 US4684623A (en) 1985-05-02 1985-11-26 Use of tumor necrosis factor as a weight regulator
PCT/US1986/000952 WO1986006280A1 (en) 1985-05-02 1986-05-01 Use of tumor necrosis factor as a weight regulator

Publications (2)

Publication Number Publication Date
DK1887D0 DK1887D0 (da) 1987-01-02
DK1887A true DK1887A (da) 1987-03-02

Family

ID=27112039

Family Applications (1)

Application Number Title Priority Date Filing Date
DK001887A DK1887A (da) 1985-05-02 1987-01-02 Anvendelse af tumornekrosefaktor som vaegtregulator

Country Status (6)

Country Link
US (1) US4684623A (da)
EP (1) EP0226603A1 (da)
AU (1) AU5862886A (da)
DK (1) DK1887A (da)
FI (1) FI865373A7 (da)
WO (1) WO1986006280A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822776A (en) * 1981-09-08 1989-04-18 The Rockefeller University Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
US6419927B1 (en) 1981-09-08 2002-07-16 Anthony Cerami Method for reducing adverse effects of a human 70kDa mediator which results from endotoxin stimulation of macrophages
US6309640B1 (en) 1981-09-08 2001-10-30 The Rockefeller University Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
US4879110A (en) * 1983-10-27 1989-11-07 Stolle Research And Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
US5102658A (en) * 1985-07-19 1992-04-07 National Research Development Corporation Antibody treatment for adiposity
EP0613006A1 (en) * 1985-08-16 1994-08-31 The Rockefeller University Antibodies to cachectin and immunoassays
US5223425A (en) * 1987-04-02 1993-06-29 The Beth Israel Hospital Association DNA encoding human adipsin with complement D activity
JP2638652B2 (ja) * 1988-07-18 1997-08-06 カイロン・コーポレーション カケクチンと反応するモノクロナール抗体
US5322699A (en) * 1991-02-04 1994-06-21 The Rockefeller University Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1)
US5560908A (en) * 1993-01-22 1996-10-01 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Therapeutic agent for NIDDM
ATE183513T1 (de) * 1993-06-03 1999-09-15 Therapeutic Antibodies Inc Herstellung von antikörperfragmenten
DK96493D0 (da) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
US6354297B1 (en) * 1998-04-16 2002-03-12 The Uniformed Services University Of The Health Sciences Method and device for destroying fat cells by induction of programmed cell death
US6180549B1 (en) * 1998-09-10 2001-01-30 The B. F. Goodrich Company Modified zeolites and methods of making thereof
US20030022856A1 (en) * 2001-01-30 2003-01-30 The Regents Of The University Of Michigan Method for sustained release local delivery of drugs for ablation of unwanted tissue
US7285269B2 (en) 2002-12-02 2007-10-23 Amgen Fremont, Inc. Antibodies directed to tumor necrosis factor
US20050222040A1 (en) * 2004-04-05 2005-10-06 Blm Group, Inc. Vertebrate peptide modulators of lipid metabolism

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same

Also Published As

Publication number Publication date
WO1986006280A1 (en) 1986-11-06
FI865373L (fi) 1986-12-31
FI865373A0 (fi) 1986-12-31
US4684623A (en) 1987-08-04
FI865373A7 (fi) 1986-12-31
EP0226603A1 (en) 1987-07-01
DK1887D0 (da) 1987-01-02
AU5862886A (en) 1986-11-18

Similar Documents

Publication Publication Date Title
DK1887A (da) Anvendelse af tumornekrosefaktor som vaegtregulator
FR2583645B1 (fr) Respirateur
BR8606543A (pt) Construcao extensivel
DK166386D0 (da) Gulvmaatte
KR860014449U (ko) 빌딩용 비전동 자동 강하 도피사다리
NO168835C (no) Marin antibegroningsmaling
BR8605640A (pt) Grampeador
KR860009401A (ko) 리일대
DK572186D0 (da) Thioxanthonderivater
FR2590195B1 (fr) Agrafeuse
BR8600290A (pt) Composicao polimerizavel
ES2018161B3 (es) Un conjunto de techo enrejillado
AT384265B (de) Getarnter hangar
DK406286D0 (da) Lyssignalgiver
FR2576313B1 (fr) Peinture intumescente
DK409486A (da) Vaegt
AT388361B (de) Arbeitsplattform
SE8506012D0 (sv) Stodbock
NO870008D0 (no) Bruk av tumor nekrosefaktor som vektregulator.
BR6500942U (pt) Escada
IT8503483A0 (it) Plafoniera componibile
KR870004708U (ko) 마당비
KR860005858A (ko) 중합가능한 조성물
AT383847B (de) Gebaeude
IT8521179U1 (it) Strutture componibili

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment